RDHL trade ideas

DEXWireNews

RedHill Biopharma files to sell 8.86M American Depositary Shares for holders

DivergenceSeeker

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of...

coldsteel_trading

See chart

UnknownUnicorn7851950

Hi. Look at this beauty. If you want new shares, like wildly and follow wildly. It is my personal opinion. It isn't investment advice.

AlTorress

This indicator may be signaling that RDHL's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. Tickeron A.I.dvisor backtested 85 similar cases where RDHL's Momentum Indicator fell below the 0 level, and 71 of them led to a successful outcome. Odds of...

RocketTickers

RDHL: RedHill Biopharma Ltd. 2020-08-27 07:00:10 RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy

RocketTickers

RDHL: RedHill Biopharma Ltd. 2020-07-31 07:00:10 RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 Study with RHB-204 for NTM Infections

arkeyrml

Personally I think the stock is forming a pullback before another surge, I do believe this stock has the potential to reach $20 in the future.

Samuel12_1980

Resistance 7.7, and above is 8. Not for a suggestion Just an Idea.

RocketTickers

RDHL: RedHill Biopharma Ltd. 2020-05-08 07:00:10 RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.

Samuel12_1980 Updated 

The first two patients have been treated with opaganib at a leading hospital in Israel. At the time of treatment initiation, both patients suffered from moderate to severe acute respiratory symptoms related to SARS-CoV-2 infection, required supplemental oxygenation and were hypoxic despite being treated with maximum flow of oxygen with cannulas. Preliminary...

Samuel12_1980

2 main resistance are 6.48 and 7 Target to 8.38 - 8.54 (Talicia's FDA Announcement). Below is 5.8 and MA200 Not for a suggestion!

Samuel12_1980 Updated 

Looks great!

DEXWireNews

RedHill Biopharma Ltd. is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating...

Samuel12_1980 Updated 

2 main supports located on Moving average 50, 20 SHS option with target to 7.13~ Not for suggestion Good-luck to all

Samuel12_1980

TEL-AVIV, Israel and RALEIGH, N.C., March 13, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company focused on gastrointestinal diseases, today announced that Express Scripts has added Talicia® (omeprazole magnesium, amoxicillin and rifabutin)1 to its National Preferred Formulary as a...

Samuel12_1980

I hope we will see upturn to the a higher price values. Not for suggestion. Just an Idea In today.

Samuel12_1980

Into the market this quarter Good-luck to the company and do not see it as suggestion!